Terms: = Liver cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Staging
11 results:
1. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner.
Deng S; Cheng D; Wang J; Gu J; Xue Y; Jiang Z; Qin L; Mao F; Cao Y; Cai K
J Exp Clin Cancer Res; 2023 Nov; 42(1):294. PubMed ID: 37926835
[TBL] [Abstract] [Full Text] [Related]
2. Reticulon 2 promotes gastric cancer metastasis via activating endoplasmic reticulum Ca
Song S; Liu B; Zeng X; Wu Y; Chen H; Wu H; Gu J; Gao X; Ruan Y; Wang H
Cell Death Dis; 2022 Apr; 13(4):349. PubMed ID: 35428758
[TBL] [Abstract] [Full Text] [Related]
3. Protective effect of the RNA-binding protein RBM10 in hepatocellular carcinoma.
Zhao Z; Li J; Shen F
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6005-6013. PubMed ID: 32572914
[TBL] [Abstract] [Full Text] [Related]
4. LASP2 is downregulated in human liver cancer and contributes to hepatoblastoma cell malignant phenotypes through MAPK/erk pathway.
Li J; Hu S; Zhang Z; Qian L; Xue Q; Qu X
Biomed Pharmacother; 2020 Jul; 127():110154. PubMed ID: 32325347
[TBL] [Abstract] [Full Text] [Related]
5. PEA15 promotes liver metastasis of colorectal cancer by upregulating the erk/MAPK signaling pathway.
Tang B; Liang W; Liao Y; Li Z; Wang Y; Yan C
Oncol Rep; 2019 Jan; 41(1):43-56. PubMed ID: 30365128
[TBL] [Abstract] [Full Text] [Related]
6. S100A11 promotes cell proliferation via p38/MAPK signaling pathway in intrahepatic cholangiocarcinoma.
Zhang MX; Gan W; Jing CY; Zheng SS; Yi Y; Zhang J; Xu X; Lin JJ; Zhang BH; Qiu SJ
Mol Carcinog; 2019 Jan; 58(1):19-30. PubMed ID: 30182496
[TBL] [Abstract] [Full Text] [Related]
7. Demethylation-Induced Overexpression of Shc3 Drives c-Raf-Independent Activation of MEK/erk in HCC.
Liu Y; Zhang X; Yang B; Zhuang H; Guo H; Wei W; Li Y; Chen R; Li Y; Zhang N
Cancer Res; 2018 May; 78(9):2219-2232. PubMed ID: 29330146
[TBL] [Abstract] [Full Text] [Related]
8. Association of IL-12 B Gene Polymorphism with staging of liver Disease in Chronic HCV Patients.
Elwan N; Amr K; Elyamany S; Elkhalawany W; Soliman S; Ziada M; Abd-Elsalam S
Infect Disord Drug Targets; 2018; 18(2):122-128. PubMed ID: 28595541
[TBL] [Abstract] [Full Text] [Related]
9. High Expression of Phosphorylated Extracellular Signal-Regulated Kinase (erk1/2) is Associated with Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.
Fan L; Hong J; Huang H; Fu D; Wu S; Wang Q; Ye Y; Liu Y
Med Sci Monit; 2017 May; 23():2636-2643. PubMed ID: 28557972
[TBL] [Abstract] [Full Text] [Related]
10. OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of erk/MAPK Pathway.
Li H; Miao Q; Xu CW; Huang JH; Zhou YF; Wu MJ
J Korean Med Sci; 2016 Aug; 31(8):1215-23. PubMed ID: 27478331
[TBL] [Abstract] [Full Text] [Related]
11. Medical treatments: in association or alone, their roles and their future perspectives: the Western experience.
Reig M; Bruix J
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):420-1. PubMed ID: 19890601
[TBL] [Abstract] [Full Text] [Related]